Dr Martin Molina is the Principal investigator of the Gene and Cell Therapy group at the department of human variability in the Centre for Genomics and Oncological Research (GENYO). He is PhD in Biology (extraordinary Price) by the CSIC-University of Granada in 1995. He worked in London from 1997 to 2003, first at the ICR Chester Beaty and then at the Windeyer Institute of Medical Sciences (UCL) where he worked on retroviral vectors targeting to tumor cells for cancer immunotherapy. From 2003 to 2009 Dr Martin Molina consolidates his own research group thanks to a Miguel Servet and a Ramon y Cajal contracts. From 2009 he is Principal Investigator from the Fundación Progreso y Sadud, first at the Andalusian Stem Cell Bank (BACM) and then at GENYO. His group main interest is the development of safer and more efficient gene delivery tools for the treatment of immune-related diseases: Immunodeficiencies (Wiskott-Aldrich Syndrome) and autoimmune diseases (Multiple sclerosis). He has published over 35 international publications in high impact journals. His publications have been cited over 710 times and have an accumulate impact factor of 202.